Epidemiology and Genetic Determinants of Diabetes Mellitus. Type 2 Diabetes In Youth: A New Epidemic; H. Dean. Undiagnosed Diabetes; Burden and Significance in the Canadian Population; T.K. Young. Genes, Environment and Diabetes in Canadian Aboriginal Communities; R.A. Hegele. Diabetes in Sub-Saharan Africa; T.J. Aspray, N. Unwin. Coronary Heart Disease and Risk Factors in Asian Indians; M. Chandalia, P.C. Deedwania. Metabolic Risk Factors in Diabetes and Cardiovascular Disease. The Plasma Glucose Level - A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People; H.C. Gerstein. Modified Lipoproteins and Cardiovascular Risk; W. Aldahi, J. Frohlich. Advances in Lipid-Lowering Therapy in Atherosclerosis; J. Davignon. Homocysteine as a Risk Factor in Cardiovascular Disease; D.E.C. Cole. Endothelial Function and Diabetes. Endothelial Integrity and Repair; T.J. Lee , et al. Molecular Mechanisms of Endothelial Dysfunction in the Diabetic Heart; P.Rösen, et al. A Study of Vascular Wound Healing in a Rabbit Model of Type I Diabetes; N.K. Schiller, et al. Endothelins in the Microvasculature and Heart in Diabetes; S,Chakrabarti, et al. Diabetes and Endothelial Function: Implications for Coronary Angioplasty; T.J. Anderson. Hypertension and diabetes mellitus. The Effect of Hypertension in Diabetes; E.D. Burgess. The Diabetic Hypertensive (or Hypertensive Diabetic) - A Compelling Need to Optimize Blood Pressure; S.G. Carruthers. Left Ventricular Diastolic Dysfunction in Diabetic or Hypertensive Subjects: Role of Collagen Alterations; T.J. Regan, et al. Alterations in the Vascular Actions of Insulin in the Pathogenesis of Insulin Resistance and Hypertension; S. Verma, J.H. McNeill. Cardiac Hypertrophy in Diabetes Patients with and without Hypertension: Effects of Troglitazone, A Novel Antidiabetic Drug, on Diastolic Function; N. Makino, et al. Cost and Benefits of Blood Pressure Monitoring and Control; A. Chockalingam, N.R.C. Campbell. Cardiac lipid metabolism in diabetes. Malonyl COA Control of Fatty Acid Oxidation in the Diabetic Rat Heart; G.D. Lopaschuk. Alterations in 1,2-Diacylglycerols and Ceramides in Diabetic Rat Heart; K. Okumura, et al. Regulations of Myocardial Phospholipid N-Methylation by Insulin and Diabetes; S.W. Schaffer, M. Mozaffari. Reduction Of Phosphatidylinositol-4,5-Bisphosphate Mass In Heart Sarcolemma During Diabetic Cardiomyopathy; P.S. Tappia, et al. Tumor Necrosis Factor-agr;, Sphingomyelinase and Ceramides Activate Tyrosine Kinase, P21ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport and Insulin Resistance; A.N. Hanna, et al. Cardiac Function and Oxidative Stress in Diabetes. Antioxidants, Free Radical Stress and Diabetes; S.S. Rastogi, R.B. Singh. Oxidative Stress and Functional Deficit in Diabetic Cardiomyopathy; P.K. Singal. Ketosis and the Generation of Oxygen Radicals in Diabetes Mellitus; S.K. Jain, K. Kannan. Effect of Diabetes Mellitus on Hemodynamic and Cardiometabolic Correlates in Experimental Myocardial Infarction; S.K. Gupta, et al. Cardiac Function in Perfused Hearts From Diabetic Mice; D.D. Belke. Mg2+-Dependent Atpase Activity In Cardiac Myofibrils From The Insulin Resistant Jcr: La-Cp Rat; T. Misra. Cyclic Nucleotide Phosphodiesterase Families in Intracellular Signalling And Diabetes; C. Lugnier. Alterations in G-Protein-Linked Signal Transduction in Cardiovascular Smooth Muscle in Diabetes; M.B. Anand-Srivastava. Glycemic Control and Improved Cardiovascular Function. Mechanism of HDL Lowering in Insulin Resistant States; G.P. Lewis et al. Insulin Treatment Post Myocardial Infarction: The Digami Study; K. Malmberg, et al. Response to Ischemia and Endogenous Myocardial Protection in the Diabetic Heart; T. Ravingerova, et al. Type 2 Diabetes: Pharmacological Intervention in an Animal Model; J.C. Russell. The Diabetic Heart and Cardiac Glycosides; M. Nagano. Hyperglycemia-Induced Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells
